Setting

North America Clinical Trials Market 2022-2031 by Product Category (Drugs, Devices, Procedures), Phase (I, II, III, IV), Design (Interventional, Observational, Expanded Access), Service Type (Site Identification, Lab Services, Supply & Logistic, Decentralized Services), Indication (Oncology, Infectious Diseases, Cardiology, Obesity, Diabetes, Neurology), End User, and Country: Trend Forecast and Growth Opportunity

Published: 30 Apr 2023 | Report Code: 10248437 | Pages: 178

North America Clinical Trials Market is projected to grow by 7.1% annually in the forecast period and reach $39,268.7 million by 2031, driven by the increasing number of clinical trials and increase in demand for novel therapies, rising prevalence of chronic diseases such as cancer and diabetes, the outbreak of tropical and infectious diseases such as COVID-19, and the increase in government initiatives and R&D investments. Highlighted with 89 tables and 75 figures, this 178-page report “North America Clinical Trials Market 2022-2031 by Product Category (Drugs, Devices, Procedures), Phase (I, II, III, IV), Design (Interventional, Observational, Expanded Access), Service Type (Site Identification, Lab Services, Supply & Logistic, Decentralized Services), Indication (Oncology, Infectious Diseases, Cardiology, Obesity, Diabetes, Neurology), End User, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America Clinical Trials Market and all its sub-segments through extensively detailed classifications.

 

Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2021-2022 and provides forecast from 2023 till 2031 with 2022 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

 

In-depth qualitative analyses include the identification and investigation of the following aspects:
•  Market Structure 
•  Growth Drivers 
•  Restraints and Challenges
•  Emerging Product Trends & Market Opportunities
•  Porter’s Five Forces

 

The trend and outlook of North America market is forecast in an optimistic, balanced, and conservative view by taking into account of COVID-19 and the Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify North America clinical trials market in every aspect of the classification from perspectives of Product Category, Phase, Design, Service Type, Indication, End User, and Country.

 

Based on Product Category, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section. 
•  Trials of Drugs
    o  Small Molecule Drugs
    o  Vaccines
    o  Cell & Gene Therapy
    o  Other Drugs
•  Trials of Devices
•  Trials of Procedures

 

Based on Phase, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section. 
•  Phase I
•  Phase II
•  Phase III
•  Phase IV

 

By Design, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section. 
•  Interventional Studies
    o  Randomized Control Trial
    o  Adaptive Clinical Trial
    o  Non-randomized Control Trial
•  Observational Studies
    o  Cohort Study
    o  Case Control Study
    o  Cross Sectional Study
    o  Ecological Study
•  Expanded Access Trials

 

By Service Type, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section. 
•  Protocol Designing
•  Site Identification
•  Patient Recruitment
•  Laboratory Services
•  Bioanalytical Testing Services
•  Clinical Trial Data Management Services
•  Clinical Trial Supply & Logistic Services
•  Decentralized Clinical Trial Services
•  Medical Device Testing Services
•  Other Clinical Trial Services

 

By Indication, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section. 
•  Oncology
•  Infectious Diseases
•  Cardiology
•  Obesity
•  Diabetes
•  Neurology
•  Immunology
•  Pain Management
•  Other Indications

 

By End User, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section. 
•  Pharmaceutical and Biotechnological Companies
•  Clinical Research Organizations
•  Clinical Testing Laboratories
•  Other End Users

 

Geographically, the following national/local markets are fully investigated:
•  U.S.
•  Canada
•  Mexico

 

For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2022-2031. The breakdown of each national market by Phase, Design, and Indication over the forecast years are also included. The report also covers the current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

 

Selected Key Players: 


Accell Clinical Research LLC
Charles River Laboratories
ClinDatrix Inc
Clinipace
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
ICON PLC
IQVIA Holdings, Inc.
Laboratory Corporation of America (Covance Inc.)
Novo Nordisk AS
PAREXEL International Corporation
Pfizer Inc.
Pharmaceutical Product Development LLC
PhlexNorth America
PRA Health Sciences
Sanofi SA
SGS SA (SGS Life Sciences)
Syneos Health Inc.
Wuxi AppTec Inc. 


(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Table of Contents:

1 Introduction    9
1.1 Industry Definition and Research Scope    9
1.1.1 Industry Definition    9
1.1.2 Research Scope    10
1.2 Research Methodology    13
1.2.1 Overview of Market Research Methodology    13
1.2.2 Market Assumption    14
1.2.3 Secondary Data    14
1.2.4 Primary Data    14
1.2.5 Data Filtration and Model Design    15
1.2.6 Market Size/Share Estimation    16
1.2.7 Research Limitations    17
1.3 Executive Summary    18
2 Market Overview and Dynamics    21
2.1 Market Size and Forecast    21
2.1.1 Impact of COVID-19 on World Economy    23
2.1.2 Impact of COVID-19 on the Market    26
2.1.3 Impact of Russia-Ukraine Conflict: War Slows Economic Recovery    28
2.2 Major Growth Drivers    32
2.3 Market Restraints and Challenges    39
2.4 Emerging Opportunities and Market Trends    42
2.5 Porter’s Fiver Forces Analysis    46
3 Segmentation of North America Market by Product Category    50
3.1 Market Overview by Product Category    50
3.2 Trials of Drugs    52
3.2.1 Small Molecule Drugs    53
3.2.2 Vaccines    54
3.2.3 Cell & Gene Therapy    55
3.2.4 Other Drugs    56
3.3 Trials of Devices    57
3.4 Trials of Procedures    58
4 Segmentation of North America Market by Phase    59
4.1 Market Overview by Phase    59
4.2 Phase I    61
4.3 Phase II    62
4.4 Phase III    63
4.5 Phase IV    64
5 Segmentation of North America Market by Design    65
5.1 Market Overview by Design    65
5.2 Interventional Studies    67
5.2.1 Randomized Control Trial    69
5.2.2 Adaptive Clinical Trial    70
5.2.3 Non-randomized Control Trial    71
5.3 Observational Studies    72
5.3.1 Cohort Study    74
5.3.2 Case Control Study    75
5.3.3 Cross Sectional Study    76
5.3.4 Ecological Study    77
5.4 Expanded Access Trials    78
6 Segmentation of North America Market by Service Type    79
6.1 Market Overview by Service Type    79
6.2 Protocol Designing    81
6.3 Site Identification    82
6.4 Patient Recruitment    83
6.5 Laboratory Services    84
6.6 Bioanalytical Testing Services    85
6.7 Clinical Trial Data Management Services    86
6.8 Clinical Trial Supply & Logistic Services    87
6.9 Decentralized Clinical Trial Services    88
6.10 Medical Device Testing Services    89
6.11 Other Clinical Trial Services    90
7 Segmentation of North America Market by Indication    91
7.1 Market Overview by Indication    91
7.2 Oncology    93
7.3 Infectious Diseases    94
7.4 Cardiology    95
7.5 Obesity    96
7.6 Diabetes    97
7.7 Neurology    98
7.8 Immunology    99
7.9 Pain Management    100
7.10 Other Indications    101
8 Segmentation of North America Market by End User    102
8.1 Market Overview by End User    102
8.2 Pharmaceutical and Biotechnological Companies    104
8.3 Clinical Research Organizations    105
8.4 Clinical Testing Laboratories    106
8.5 Other End Users    107
9 North America Market 2021-2031 by Country    108
9.1 Overview of North America Market    108
9.2 U.S.    111
9.3 Canada    114
9.4 Mexico    116
10 Competitive Landscape    118
10.1 Overview of Key Vendors    118
10.2 New Product Launch, Partnership, Investment, and M&A    122
10.3 Company Profiles    123
Accell Clinical Research LLC    123
Charles River Laboratories    125
ClinDatrix Inc    128
Clinipace    129
Eli Lilly and Company    131
F. Hoffmann-La Roche Ltd.    134
ICON PLC    137
IQVIA Holdings, Inc.    140
Laboratory Corporation of America (Covance Inc.)    144
Novo Nordisk AS    148
PAREXEL International Corporation    151
Pfizer Inc.    155
Pharmaceutical Product Development LLC    160
Phlexglobal    163
PRA Health Sciences    165
Sanofi SA    167
SGS SA (SGS Life Sciences)    170
Syneos Health Inc.    173
Wuxi AppTec Inc.    176
RELATED REPORTS    178

 

List of Tables:

Table 1. Snapshot of North America Clinical Trials Market in Balanced Perspective, 2022-2031    19
Table 2. Total Number of Registered Clinical Studies Worldwide, 2010-2021    22
Table 3. World Economic Outlook, 2021-2031    24
Table 4. World Economic Outlook, 2021-2023    25
Table 5. Scenarios for Economic Impact of Ukraine Crisis    29
Table 6. World Health Spending by Region, $ bn, 2013-2020    38
Table 7. Main Product Trends and Market Opportunities in North America Clinical Trials Market    42
Table 8. North America Clinical Trials Market by Product Category, 2021-2031, $ mn    50
Table 9. North America Clinical Trials Market: Trials of Drugs by Drug Type, 2021-2031, $ mn    52
Table 10. North America Clinical Trials Market by Phase, 2021-2031, $ mn    59
Table 11. North America Clinical Trials Market by Design, 2021-2031, $ mn    65
Table 12. North America Clinical Trials Market: Interventional Studies by Segment, 2021-2031, $ mn    68
Table 13. North America Clinical Trials Market: Observational Studies by Segment, 2021-2031, $ mn    73
Table 14. North America Clinical Trials Market by Service Type, 2021-2031, $ mn    79
Table 15. North America Clinical Trials Market by Indication, 2021-2031, $ mn    91
Table 16. North America Clinical Trials Market by End User, 2021-2031, $ mn    102
Table 17. North America Clinical Trials Market by Country, 2021-2031, $ mn    109
Table 18. U.S. Clinical Trials Market by Phase, 2021-2031, $ mn    113
Table 19. U.S. Clinical Trials Market by Design, 2021-2031, $ mn    113
Table 20. U.S. Clinical Trials Market by Indication, 2021-2031, $ mn    113
Table 21. Canada Clinical Trials Market by Phase, 2021-2031, $ mn    115
Table 22. Canada Clinical Trials Market by Design, 2021-2031, $ mn    115
Table 23. Canada Clinical Trials Market by Indication, 2021-2031, $ mn    115
Table 24. Mexico Clinical Trials Market by Phase, 2021-2031, $ mn    117
Table 25. Mexico Clinical Trials Market by Design, 2021-2031, $ mn    117
Table 26. Mexico Clinical Trials Market by Indication, 2021-2031, $ mn    117
Table 27. Percentage of Registered Studies by Location (as of February 24, 2022)    120
Table 28. Percentage of Recruiting Studies by Location (as of February 24, 2022)    120
Table 29. Accell Clinical Research LLC: Company Snapshot    123
Table 30. Accell Clinical Research LLC: Business Segmentation    124
Table 31. Accell Clinical Research LLC: Product Portfolio    124
Table 32. Charles River Laboratories: Company Snapshot    125
Table 33. Charles River Laboratories: Product Portfolio    126
Table 34. Charles River Laboratories: Breakdown of Revenue by Division    126
Table 35. Charles River Laboratories: Breakdown of Revenue by Region    127
Table 36. ClinDatrix Inc: Company Snapshot    128
Table 37. Clinipace: Company Snapshot    129
Table 38. Clinipace: Product Portfolio    130
Table 39. Eli Lilly and Company: Company Snapshot    131
Table 40. Eli Lilly and Company: Pharmaceutical Brands    132
Table 41. Eli Lilly and Company: Clinical Trial Service    132
Table 42. Eli Lilly and Company: Breakdown of Revenue by Therapeutic Area    132
Table 43. Eli Lilly and Company: Breakdown of Revenue by Region    133
Table 44. F. Hoffmann-La Roche: Company Snapshot    134
Table 45. F. Hoffmann-La Roche: Clinical Trial Service    134
Table 46. F. Hoffmann-La Roche: Business Segmentation    135
Table 47. F. Hoffmann-La Roche: Revenue by Region    135
Table 48. ICON Plc: Company Snapshot    137
Table 49. ICON Plc: Business Segmentation    137
Table 50. ICON Plc: Product Portfolio    138
Table 51. ICON Plc: Revenue by Region, 2020, 8
Table 52. IQVIA Holdings Inc.: Company Snapshot    140
Table 53. IQVIA Holdings Inc.: Business Segmentation    141
Table 54. IQVIA Holdings Inc.: Revenue by Region, 2020, 1
Table 55. IQVIA Holdings Inc.: Product Portfolio    142
Table 56. Covance Inc.: Company Snapshot    144
Table 57. Covance Inc.: Product Portfolio    145
Table 58. Covance Inc.: Revenue by Region, 2020, 6
Table 59. Novo Nordisk: Company Snapshot    148
Table 60. Novo Nordisk: Product Portfolio    149
Table 61. Novo Nordisk: Breakdown of Revenue by Business Segment    150
Table 62. Novo Nordisk: Breakdown of Revenue by Region    150
Table 63. PAREXEL International Corporation: Company Snapshot    151
Table 64. PAREXEL International Corporation: Business Segmentation    152
Table 65. PAREXEL International Corporation: Revenue by Region, 2018, 2
Table 66. PAREXEL International Corporation: Product Portfolio    153
Table 67. Pfizer Inc.: Company Snapshot    155
Table 68. Pfizer Inc.: Business Segmentation    156
Table 69. Pfizer Inc.: Breakdown of Revenue by Product Category    156
Table 70. Pfizer Inc.: Breakdown of Revenue by Region    157
Table 71. Pfizer Inc.: Product Portfolio    157
Table 72. Pfizer Inc.: Revenue, 2018-2020, $ bn    158
Table 73. Pharmaceutical Product Development LLC (PPD): Company Snapshot    160
Table 74. Pharmaceutical Product Development LLC (PPD): Breakdown of Revenue by Division    161
Table 75. Pharmaceutical Product Development LLC (PPD): Breakdown of Revenue by Region    161
Table 76. Phlexglobal: Company Snapshot    163
Table 77. PRA Health Sciences Inc.: Company Snapshot    165
Table 78. PRA Health Sciences Inc.: Business Segmentation    166
Table 79. PRA Health Sciences Inc.: Revenue by Region, 2018, 6
Table 80. Sanofi: Company Snapshot    167
Table 81. Sanofi: Business Segmentation    168
Table 82. Sanofi: Breakdown of Revenue by Region    168
Table 83. SGS SA (SGS Life Sciences): Company Snapshot    170
Table 84. SGS SA (SGS Life Sciences): Business Segmentation    171
Table 85. SGS SA (SGS Life Sciences): Revenue by Region, 2018, 1
Table 86. Syneos Health Inc.: Company Snapshot    173
Table 87. Syneos Health Inc.: Business Segmentation    174
Table 88. Syneos Health Inc.: Revenue by Region, 2020, 4
Table 89. WuXi AppTec Inc.: Company Snapshot    176

 

List of Figures:

Figure 1. Research Method Flow Chart    13
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation    16
Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2022-2031    18
Figure 4. North America Clinical Trials Market, 2021-2031, $ mn    21
Figure 5. Impact of COVID-19 on Business    26
Figure 6. Primary Drivers and Impact Factors of North America Clinical Trials Market    32
Figure 7. Percentage of Trial Participants by Country, 2015-2019    35
Figure 8. Leading Causes of Death in the World, 2000 and 2019, million    36
Figure 9. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million    37
Figure 10. World Population 65 and Over, % of Total Population, 1950-2060    37
Figure 11. Primary Restraints and Impact Factors of North America Clinical Trials Market    39
Figure 12. Investment Opportunity Analysis    43
Figure 13. Porter’s Fiver Forces Analysis of North America Clinical Trials Market    46
Figure 14. Breakdown of North America Clinical Trials Market by Product Category, 2021-2031, % of Revenue    51
Figure 15. North America Addressable Market Cap in 2023-2031 by Product Category, Value ($ mn) and Share (%)    51
Figure 16. North America Clinical Trials Market by Product Category: Trials of Drugs, 2021-2031, $ mn    52
Figure 17. North America Clinical Trials Market by Trials of Drugs: Small Molecule Drugs, 2021-2031, $ mn    53
Figure 18. North America Clinical Trials Market by Trials of Drugs: Vaccines, 2021-2031, $ mn    54
Figure 19. North America Clinical Trials Market by Trials of Drugs: Cell & Gene Therapy, 2021-2031, $ mn    55
Figure 20. North America Clinical Trials Market by Trials of Drugs: Other Drugs, 2021-2031, $ mn    56
Figure 21. North America Clinical Trials Market by Product Category: Trials of Devices, 2021-2031, $ mn    57
Figure 22. North America Clinical Trials Market by Product Category: Trials of Procedures, 2021-2031, $ mn    58
Figure 23. Breakdown of North America Clinical Trials Market by Phase, 2021-2031, % of Sales Revenue    60
Figure 24. North America Addressable Market Cap in 2023-2031 by Phase, Value ($ mn) and Share (%)    60
Figure 25. North America Clinical Trials Market by Phase: Phase I, 2021-2031, $ mn    61
Figure 26. North America Clinical Trials Market by Phase: Phase II, 2021-2031, $ mn    62
Figure 27. North America Clinical Trials Market by Phase: Phase III, 2021-2031, $ mn    63
Figure 28. North America Clinical Trials Market by Phase: Phase IV, 2021-2031, $ mn    64
Figure 29. Breakdown of North America Clinical Trials Market by Design, 2021-2031, % of Sales Revenue    66
Figure 30. North America Addressable Market Cap in 2023-2031 by Design, Value ($ mn) and Share (%)    66
Figure 31. North America Clinical Trials Market by Design: Interventional Studies, 2021-2031, $ mn    67
Figure 32. North America Clinical Trials Market by Interventional Studies: Randomized Control Trial, 2021-2031, $ mn    69
Figure 33. North America Clinical Trials Market by Interventional Studies: Adaptive Clinical Trial, 2021-2031, $ mn    70
Figure 34. North America Clinical Trials Market by Interventional Studies: Non-randomized Control Trial, 2021-2031, $ mn    71
Figure 35. North America Clinical Trials Market by Design: Observational Studies, 2021-2031, $ mn    72
Figure 36. North America Clinical Trials Market by Observational Studies: Cohort Study, 2021-2031, $ mn    74
Figure 37. North America Clinical Trials Market by Observational Studies: Case Control Study, 2021-2031, $ mn    75
Figure 38. North America Clinical Trials Market by Observational Studies: Cross Sectional Study, 2021-2031, $ mn    76
Figure 39. North America Clinical Trials Market by Observational Studies: Ecological Study, 2021-2031, $ mn    77
Figure 40. North America Clinical Trials Market by Design: Expanded Access Trials, 2021-2031, $ mn    78
Figure 41. Breakdown of North America Clinical Trials Market by Service Type, 2021-2031, % of Revenue    80
Figure 42. North America Addressable Market Cap in 2023-2031 by Service Type, Value ($ mn) and Share (%)    80
Figure 43. North America Clinical Trials Market by Service Type: Protocol Designing, 2021-2031, $ mn    81
Figure 44. North America Clinical Trials Market by Service Type: Site Identification, 2021-2031, $ mn    82
Figure 45. North America Clinical Trials Market by Service Type: Patient Recruitment, 2021-2031, $ mn    83
Figure 46. North America Clinical Trials Market by Service Type: Laboratory Services, 2021-2031, $ mn    84
Figure 47. North America Clinical Trials Market by Service Type: Bioanalytical Testing Services, 2021-2031, $ mn    85
Figure 48. North America Clinical Trials Market by Service Type: Clinical Trial Data Management Services, 2021-2031, $ mn    86
Figure 49. North America Clinical Trials Market by Service Type: Clinical Trial Supply & Logistic Services, 2021-2031, $ mn    87
Figure 50. North America Clinical Trials Market by Service Type: Decentralized Clinical Trial Services, 2021-2031, $ mn    88
Figure 51. North America Clinical Trials Market by Service Type: Medical Device Testing Services, 2021-2031, $ mn    89
Figure 52. North America Clinical Trials Market by Service Type: Other Clinical Trial Services, 2021-2031, $ mn    90
Figure 53. Breakdown of North America Clinical Trials Market by Indication, 2021-2031, % of Revenue    92
Figure 54. North America Addressable Market Cap in 2023-2031 by Indication, Value ($ mn) and Share (%)    92
Figure 55. North America Clinical Trials Market by Indication: Oncology, 2021-2031, $ mn    93
Figure 56. North America Clinical Trials Market by Indication: Infectious Diseases, 2021-2031, $ mn    94
Figure 57. North America Clinical Trials Market by Indication: Cardiology, 2021-2031, $ mn    95
Figure 58. North America Clinical Trials Market by Indication: Obesity, 2021-2031, $ mn    96
Figure 59. North America Clinical Trials Market by Indication: Diabetes, 2021-2031, $ mn    97
Figure 60. North America Clinical Trials Market by Indication: Neurology, 2021-2031, $ mn    98
Figure 61. North America Clinical Trials Market by Indication: Immunology, 2021-2031, $ mn    99
Figure 62. North America Clinical Trials Market by Indication: Pain Management, 2021-2031, $ mn    100
Figure 63. North America Clinical Trials Market by Indication: Other Indications, 2021-2031, $ mn    101
Figure 64. Breakdown of North America Clinical Trials Market by End User, 2021-2031, % of Revenue    102
Figure 65. North America Addressable Market Cap in 2023-2031 by End User, Value ($ mn) and Share (%)    103
Figure 66. North America Clinical Trials Market by End User: Pharmaceutical and Biotechnological Companies, 2021-2031, $ mn    104
Figure 67. North America Clinical Trials Market by End User: Clinical Research Organizations, 2021-2031, $ mn    105
Figure 68. North America Clinical Trials Market by End User: Clinical Testing Laboratories, 2021-2031, $ mn    106
Figure 69. North America Clinical Trials Market by End User: Other End Users, 2021-2031, $ mn    107
Figure 70. Breakdown of North America Clinical Trials Market by Country, 2022 and 2031, % of Revenue    109
Figure 71. Contribution to North America 2023-2031 Cumulative Market by Country, Value ($ mn) and Share (%)    110
Figure 72. U.S. Clinical Trials Market, 2021-2031, $ mn    112
Figure 73. Canada Clinical Trials Market, 2021-2031, $ mn    114
Figure 74. Clinical Trials Market in Mexico, 2021-2031, $ mn    116
Figure 75. Growth Stage of North America Clinical Trials Industry over the Forecast Period    118
Selected Key Players: 

Accell Clinical Research LLC
Charles River Laboratory
ClinDatrix Inc
Clinipace
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
ICON PLC
IQVIA Holdings, Inc.
Laboratory Corporation of America
Novo Nordisk AS
PAREXEL International Corporation
Pfizer Inc.
Pharmaceutical Product Development LLC
PRA Health Sciences
Sanofi SA
SGS SA
Syneos Health Inc.
Wuxi AppTec Inc. 

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)